1 / 52

Outline …

Explore characteristics of restrictive and obstructive lung diseases, assessment through spirometry tests, and possible disturbances in ventilation and perfusion. Learn about lung fibrosis, thoracic deformities, and pulmonary function assessments.

mcleanl
Download Presentation

Outline …

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 1 introduction, respiratory insufficiency2 spirometric classification, restrictive 3 and obstructive diseases4 ventilation/ to perfusion ratio and other amendments / 65

  2. Outline … • Context – four possible disturbances of pulmonary function; insufficienly • Static characteristics of the lung – intrapleural pressure, surfactant, restrictive disease • Dynamic characteristics of the lung – obstructive disease • Typical obstructive diseases • Typical restrictive disease – lung fibrosis • Assesment of ventilatory // = spirometry etc.

  3. Selected spirometric parameters and tests • Breathing in rest: ventilatory rate (f/min) (~ 12 breaths / min) • Minute ventilaton (volume/min) 6-8 L/min - FVC - Forced vital capacityTotal volume exhaled during the forced expirationf: [21.7 – (0.101 x age[y])] × (cm) = (mL) m: [27.63 – (0.112 x age[y])] × (cm) = (mL)Values between 80 to 120 % of predicted are considered to be normal -MVV (Vmax) = Maximal voluntary ventilationmaximal tidal volume (TV) and maximal ventilatory rate measured for 10 – 30 sec > 40 L/min - Ventilatory reserve: minute ventilation / MVV > 1 : 5 = 1 : 2

  4. Regression equation for vital capacity: Women: [21.7 – (0.101 x age[y])] ×h (cm) = (mL) Men: [27.63 – (0.112 x age[y])] × h (cm) = (mL) / 65

  5. Restrictive diseases anatomical and/or functional loss of surface for gas exchange resection atelectasis lung edema lung fibrosis thoracic deformities / impaired breathing movements pneumonia pneumothorax

  6. Characteristics - decreased vital capacity (VC) • decreased function residual capacity (FRC)/ =exspiratory reserve vol. + residual vol. - decreased compliance - normal shape of flow volume loops • more negative intrapleural pressure during inspiration • increased in pulmonary vascular resistance - hypoxemia

  7. Possible respiratory system disturbances • // ventilation • // perfusion • // distribution of ventilation and per-fusion = ventilation perfusion mismatch • // diffusion

  8. Spirogram - restrictive disease

  9. Air Water Blood Tissues Fish

  10. Air Water Blood Tissues Fish (Anabas)

  11. Air Water Blood Tissues Fish (Anabas) (Lungfish)

  12. Air Water Blood Tissues Fish (Anabas) (Lungfish) Amphibians Amphibians

  13. Air Water Blood Tissues Fish (Anabas)/ Fossil (Lungfish) Amphibians Amphibians Terrestrial/ Mammals

  14. Pinsp Pexp Rinsp Rexp P=2T/R Rinsp<Rexp Pinsp>Pexp

  15. gravitation

  16. Transthoracic pressure Palv Transpulmonary pressure Palv Palv Ppl

  17. Pressure – Volume Static Curves TLC Thoracicchest % VitalCapacity Lungsandthoracicchest Lungs expirium Lungsandthoracicchest ThoracicChest Inspirium Lungs FRC RV -5 cm H20 Pressure (cm H2O)

  18. Pressure – Volume Static Curves Lungsandthoracicchest TLC Complianceincreasing Compliancedecreasing insp VT FRC RV -5 Pleuralpressure(cm H2O)

  19. Cross-section 2 mm Resistance Totalcrosssection 85-95% resistance

  20. 760 mmHg = 1 atm = 1000 cmH2O = 101 kPa =~100 % 1 dyne = 10 uN, 1 Pa = 1 N/m2

  21. Stability of alveoli

  22. Compliance – effect of surfactant

  23. Surfactant

  24. P = T / (2R) bez surfaktantu: R P = T/ (2R) se surfaktantem: R T P = T / (2R) bez surfaktantu: R P = T/ (2R) se surfaktantem: R T P = T / (2R)

  25. The „most important“ measureof respiratory system function • pO2 & pCO2 in arterial blood - („Astrup“) • O2 solubility in water is low => need of Hemoglobin • pO2 = 13,3 kPa = 100 Torr • Conversion: 1 Atm = 10 m H2O = 100 kPa = 760 Torr = 760 mmHg …….. 1 kPa = 10 cm H2O = 7,6 Torr • pCO2 = 40 Torr = 5,3 kPa

  26. FiCO2=0 VCO2 Alveolar ventilation VCO2 = FACO2 * VA VA FACO2× VA = VCO2/FACO2 VCO2 PACO2 = FACO2×Barometric pressure VA = k1×VCO2/PACO2 PACO2 = k2×VCO2/VA STPD BTPS P×V (P-PH2O)×VBTPS 760×VBTPS T 273+ t°patient 273 = R = PACO2[torr] = 0,863*VCO2[ml/min STPD]/VA[l/min BTPS]

  27. ViO2=FiO2×VA VEO2=FAO2×VA PACO2 VA PAO2 VEO2 ViO2 VO2=ViO2-VEO2 VO2=FiO2×VA - FAO2×VA FAO2=FiO2 - VO2/VA PAO2=PiO2 - k×VO2/VA VA PACO2[torr] = 0,863*VCO2[ml/min STPD]/VA[l/min BTPS]

  28. Alveolar Ventilation Controls Rate of Breathingby Influencing pCO2 and pO2 VA VE=VD+VA Respir.Centre pO2 pCO2 Only whenpO2is low VA pCO2 pO2 pO2 pCO2

  29. Ventilation disorders • Lung impairment (mechanical properties change) • Obstructive disease - ↑ increased resistance R of airways (R = “dynamic lung resistance”) • Restrictivedisease– ↓decreasedlung compliance C (‘↑ static resistance” `;C = 1/ static lung resistance) • Chest wall impairment • ↓ decreased C of chest wall – severe scoliosis, extensive fibrosis, serial fractures • Insufficient activity of respiratory muscles (// innervation or // muscle strength , // of CNS )– E.g.. Respiratory centre suppression in barbiturate poisoning, myasthenia gravis

  30. Lung fibrosis = Interstitial lung disease (ILD) • = diffuse parenchymal lung disease • Inflamation in alveolar wall leads to scarring and collagen deposition • Chest X-ray, pulmonary function testing, (lung biopsy) • Affect the alveolar wall or the interstice of the lung (alveolar epithelium, capillary endothelium, basal membrane, interstice and perilymphatic tissue) • Fibrosis may be a late sign

  31. Causes of lung fibrosis/ ILD • Inhalation of particles • 1.Azbestosis, silicosis, pneumoconiosis,= Pneumokonioser • 2.hypersensitivity (farmer’s lung)= Alveolitis allergica • Drug induced (Abio, chemo, Antiarrhythmic)= • Connective tissue disease: Systemic sclerosis, Dermatomyositis, SLE, RA • Infection: Atypical pneumonia, pneumocystis, TBC • Lymphangitic carcinoma= maligne sygdromme Idiopatic: Sarcoidosis • Idiopathic pulmonary fibrosis= Alveolitis fibrosa

  32. Fibrosing alveolitis= Idiopathic pulmonary fibrosis • Unknown cause – Autoimmunity? • People after 50 / 3 years life expectancy • Symptoms: • Tachypnoe, cyanosis, finger clubbing • Dg: • Chest X-ray • HRCT • Spirometry/whole body pletysmography • Blood gas analysis • Inflamatory and autoimmunity testing • Biopsy and histology: Histology: Usual interstitial pneumonia

  33. Possible respiratory system disturbances • // ventilation • // perfusion • // distribution of ventilation and per-fusion = ventilation perfusion mismatch • // diffusion

  34. Ventilation • Is carried out by respiratory muscles, that change volume of thorax. • Volume changes cause changes of pressures • Changes of pressure in alveoli cause air flow (↑ pressure – expiration; ↓ pressure – inspiration) flow behaves according to Ohm’s law

  35. Ventilation disorders • Lung impairment (mechanical properties change) • Obstructive disease - ↑ increased resistance R of airways (R = “dynamic lung resistance”) • Restrictivedisease– ↓decreasedlung compliance C (‘↑ static resistance” `;C = 1/ static lung resistance) • Chest wall impairment • ↓ decreased C of chest wall – severe scoliosis, extensive fibrosis, serial fractures • Insufficient activity of respiratory muscles (// innervation or // muscle strength , // of CNS )– E.g.. Respiratory centre suppression in barbiturate poisoning, myasthenia gravis

  36. Normal/ Restrictive/ Obstructive

  37. Why the airplane flies?

  38. Bronchiolus narrows (broncho-constriction, mucus…)

  39. What did we cover • Context – four possible disturbances of pulmonary function; insufficienly • Static characteristics of the lung – intrapleural pressure, surfactant, restrictive disease • Dynamic characteristics of the lung – obstructive disease • Typical obstructive diseases • Typical restrictive disease – lung fibrosis • Assesment of ventilatory // = spirometry etc.

More Related